Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-03-003987
Filing Date
2003-03-14
Accepted
2003-03-14 17:21:32
Documents
4
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d03838e10vk.htm 10-K 805330
3 EX-11.1 RE: COMPUTATION OF PER SHARE EARNINGS d03838exv11w1.txt EX-11.1 3297
4 EX-23.1 CONSENT OF ERNST & YOUNG LLP d03838exv23w1.txt EX-23.1 884
5 EX-23.2 INFORMATION RE: CONSENT OF ARTHUR ANDERSEN d03838exv23w2.txt EX-23.2 2515
  Complete submission text file 0000950134-03-003987.txt   813967
Mailing Address 14785 OMICRON DR SUITE 101 SAN ANTONIO TX 78245
Business Address 4545 HORIZON HILL BLVD SAN ANTONIO TX 78229 2109498200
ILEX ONCOLOGY INC (Filer) CIK: 0001001915 (see all company filings)

EIN.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22147 | Film No.: 03604754
SIC: 2836 Biological Products, (No Diagnostic Substances)